GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Potassium Citrate ER Tablet 540mg
B) Potassium Citrate ER Tablet 1080mg
C) Potassium Citrate ER Tablet 1620mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Potassium Citrate ER Tablet 540mg
Each Film-coated Extended-Release tablet contains:
Potassium Citrate IP………………….540mg
(as a monohydrate)
Excipients………………………………………..q.s.
Colour: Quinoline Yellow

B) Potassium Citrate ER Tablet 1080mg
Each Film-coated Extended-Release tablet contains:
Potassium Citrate IP………………….1080mg
(as a monohydrate)
Excipients………………………………………..q.s.
Colour: Red Oxide of Iron

C) Potassium Citrate ER Tablet 1620mg
Each Film-coated Extended-Release tablet contains:
Potassium Citrate IP………………….16200mg
(as a monohydrate)
Excipients………………………………………..q.s.
Colour: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. It is also used to prevent kidney stones that may occur with gout. Potassium citrate is a urinary alkalinizer.

CAUTION & WARNING:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at 20° to 25°C (68° to 77°F). Store in cool, dry & dark place Protect from Light & moisture
Dosage: As directed by the Physician

Potassium Citrate ER Tablet 540mg Technical Specification:

Product Name: Potassium Citrate ER Tablet
Brand Name: Generic
Strength: 540mg, 1080mg, 1620mg
Dosage Form: Tablets (Un-coated, Extended Release)
Route of Administration: Via Oral Route
Packing: 10s, 30s, 100s, 500s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Diuretics
Indication: Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. It is also used to prevent kidney stones that may occur with gout. Potassium citrate is a urinary alkalinizer
Storage: Store at 20° to 25°C (68° to 77°F). Store in cool, dry & dark place Protect from Light & moisture

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Potassium Citrate ER Tablet 540mg
  • Potassium Citrate ER Tablet 1080mg
  • Potassium Citrate ER Tablet 1620mg 

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Potassium Citrate ER Tablet 540mg
    Each Film-coated Extended-Release tablet contains:
    Potassium Citrate IP………………….540mg
    (as a monohydrate)
    Excipients………………………………………..q.s.
    Colour: Quinoline Yellow

  • Potassium Citrate ER Tablet 1080mg
    Each Film-coated Extended-Release tablet contains:
    Potassium Citrate IP………………….1080mg
    (as a monohydrate)
    Excipients………………………………………..q.s.
    Colour: Red Oxide of Iron
  • Potassium Citrate ER Tablet 1620mg
    Each Film-coated Extended-Release tablet contains:
    Potassium Citrate IP………………….16200mg
    (as a monohydrate)
    Excipients………………………………………..q.s.
    Colour: Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

  • Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. It is also used to prevent kidney stones that may occur with gout. Potassium citrate is a urinary alkalinizer. 

CAUTION & SCHEDULE:

  • CAUTION: Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    SWALLOW WHOLE DO NOT CHEW OR CRUSH
  • SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

  • Storage: Store at 20° to 25°C (68° to 77°F). Store in cool, dry & dark place Protect from Light & moisture
  • Dosage: As directed by the Physician